Namita Bhyravbhatla

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Epigenetic regulation of cancer-associated fibroblast heterogeneity”.

Epigenetic regulation of cancer-associated fibroblast heterogeneity

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer(2023)10.1016/j.bbcan.2023.188901

N/A

0.578DataRank · unranked

46 citations

Namita Bhyravbhatla, Surinder K. Batra, Sushil Kumar, Rachel J Kehrberg

Therapeutic implications of SARS-CoV-2 dysregulation of the gut-brain-lung axis

World Journal of Gastroenterology(2021)10.3748/wjg.v27.i29.4763

N/A

0DataRank · unranked

21 citations

Omalla A. Olwenyi, Namita Bhyravbhatla, Michellie Thurman, Kabita Pandey, Elizabeth Klug +9 more

MUC16 Promotes Liver Metastasis of Pancreatic Ductal Adenocarcinoma by Upregulating NRP2-Associated Cell Adhesion

Molecular Cancer Research(2022)10.1158/1541-7786.mcr-21-0888

N/A

0DataRank · unranked

55 citations

Imayavaramban Lakshmanan, Sakthivel Muniyan, Shailendra K. Gautam, Rama Krishna Nimmakayala, Sanchita Rauth +11 more

Cytokines chattering in pancreatic ductal adenocarcinoma tumor microenvironment

Seminars in Cancer Biology(2022)10.1016/j.semcancer.2022.03.021

N/A

0DataRank · unranked

48 citations

Namita Bhyravbhatla, Andrew Kisling, Xiaoqi Li, Surinder K. Batra, Sushil Kumar +1 more

MUC16 and TP53 family co-regulate tumor-stromal heterogeneity in pancreatic adenocarcinoma

Frontiers in Oncology(2023)10.3389/fonc.2023.1073820

N/A

0DataRank · unranked

15 citations

Vi Dam, Rama Krishna Nimmakayala, Zahraa Wajih Alsafwani, Namita Bhyravbhatla, Imayavaramban Lakshmanan +6 more

Targeting cancer-associated fibroblast-driven LIF/LIFR axis improves the therapeutic efficacy of gemcitabine and nab-paclitaxel in pancreatic cancer

npj Precision Oncology(2025)10.1038/s41698-025-01046-w

N/A

0DataRank · unranked

9 citations

Imran Khan, Xiaoqi Li, Shailendra K. Gautam, Parthasarathy Seshacharyulu, Zahraa Wajih Alsafwani +10 more